Compound ID | 1615
Class: Nucleoside analogue
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | Flavin-dependent thymidylate synthase inhibitor; ThyX inhibitor |
| Target Pathogen: | Active against Staphylococcus aureus, Mycobacterium smegmatis, Escherichia coli, and Pseudomonas aeruginosa |
| Institute where first reported: | Russian Academy of Sciences, Moscow, Russia |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.nature.com/articles/s41429-019-0158-z |